Position in NERV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$562,180
+$480,238 QoQ
Shares Held
93,308
+153.0% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. NERV ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in NERV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $562,180 | 93,308 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $81,942 | 36,878 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $61,539 | 23,049 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $73,525 | 23,049 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,560 | 23,086 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $153,662 | 24,986 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||